Thank you for your interest in clinical research.
Below are links to our current studies that need volunteer participants. If you are interested in volunteering for a current study, or if you would like to be on our contact list for future studies, please contact email@example.com or call 902-470-8141. Participants are compensated.
Phase 3 Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
Participants needed: 16-40 years old, female
The purpose of this clinical trial is to evaluate the safety and effectiveness of an investigational vaccine against cytomegalovirus (CMV) infection in women who have not had prior CMV infection and evaluate its safety in women who test positive for CMV due to prior exposure.Learn More About This Study
Understanding the effects of public health outbreak control policies and implementation on individuals and communities: A path to improving COVID-19 policy effectiveness
Participants needed:Learn More About This Study
Participants needed: Ages 18-40
Pneumococcal conjugate vaccines (PCVs) are lifesaving tools for children and cover 10, 13 or 20 varieties (or serotypes) of pneumococcus, but don’t yet cover some important serotypes that remain threats.
This early-stage Phase 1/2 clinical study will evaluate safety and immunogenicity (ability to produce an immune response) of a new PCV developed by Inventprise. The study vaccine is designed to cover 25 serotypes of pneumococcus posing greatest risk to children globally, but particularly in low- and middle-income regions where the pneumococcal disease burden is highest.Learn More About This Study
Participants needed: age 18-45
In this study, we will test a new mRNA vaccine against one type of influenza (also known as flu) virus. This study will look at how the body reacts to a Flu mRNA vaccine at different doses. We will give study participants different dose levels of this vaccine (this is called dose escalation). The good and bad effects of the mRNA vaccine will be studied.Learn More About This Study